Table 2.
Indicator | References |
---|---|
Activity/Performance Indicators | |
% of in-patients prescribed antibiotics in a single PPS/ over specific time periods, e.g., successive waves of COVID-19 | [19,61,112,172] |
% of antibiotics prescribed by defined daily doses (DDDs), e.g., DDDs/1000 patient-days in a PPS or over a specified time | [171,173,174,175] |
% of a course of antibiotics prescribed (duration) in accordance with agreed guidance/ Days of antibiotic therapy per 1000 patient-days | [166,176] |
% of antibiotics administered to in-patients within the first hour of prescribing within a designated period of time | [177] |
% of patients where the indication for prescribing and/ or stop and review dates are included in patients’ notes | [15,19,76,81,114,168,169,178,179] |
% oral vs. IV antibiotics (including as part of de-escalation policies) | [15,76,82,114,166,168,171,178,179,180,181] |
% of missed doses documented in patients’ notes, e.g., as part of a PPS | [19,148] |
% of antibiotics prescribed by their international non-proprietary name, e.g., as part of a PPS | [182,183] |
% compliance to agreed process measures surrounding AMS | [184] |
% of patients prescribed antibiotics within the country’s essential medicine list over an agreed period of time | [61,171,180,182,183] |
Process quality indicators | |
% of in-patients prescribed antibiotics in adherence to agreed guidelines within a specified time period/part of a PPS | [81,112,134,168,184,185,186,187,188,189,190,191] |
% of patients prescribed a course of antibiotics in accordance with guideline duration recommendations within a specified time period/ part of a PPS | [166,176] |
% of patients where cultures are taken and sent for analysis to guide antibiotic prescribing/ targeted therapy within a specified time period/ part of a PPS | [76,114,169,192] |
% of antibiotics prescribed based on the AWaRe classification/% reduction in the prescribing of target antibiotics, e.g., ‘Watch’ cephalosporins to potential ‘Access’ antibiotics (current target is 60% of current prescribing should be ‘Access’ antibiotics) | [60,76,81,193] |
% of patients prescribed antibiotics post-operatively to prevent SSIs/% appropriate use of antibiotics to prevent SSIs during an agreed time period | [194,195] |
% of key antibiotics available for prescribing/ Whether there are agreed therapeutic interchange policies in the hospital when there are likely to be shortages of standard antibiotics for the condition (over a specific time period) | [183,196] |
% of all admitted patients with pneumonia to the hospital correctly classified and treated to agreed guidelines (over a specified time period) | [187,190] |
Outcome Indicators | |
% SSIs following operations (over an agreed time period) | [160,194,197] |
% Mortality rates (post-intervention versus pre-intervention) following changes in antimicrobial prescribing, e.g., reducing extensive antimicrobial prescribing post-surgery for SAP or reducing extensive prescribing of ‘Watch’ antibiotics | [175,176,193] |
AMS: Antimicrobial Stewardship; DDDs: Defined Daily Doses; SAP: Surgical Antibiotic prophylaxis; SSIs: surgical site infections.